GILD34:BVMF
Gilead Sciences Inc BDR
R$65,81
0,00%
(0,00) 1D
16 ຕ.ລ., 16 ໂມງ 56 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GILD34...
Open
R$66,36
High
R$66,41
Low
R$65,81
Mkt. cap
193,67 ຕື້
Avg. vol.
261,00
Volume
0,00
52-wk high
R$67,38
52-wk low
R$51,33
Shares outstanding
1,24 ຕື້
No. of employees
17 ພັນ
Open
R$66,36
High
R$66,41
Low
R$65,81
Mkt. cap
193,67 ຕື້
Avg. vol.
261,00
Volume
0,00
52-wk high
R$67,38
52-wk low
R$51,33
Shares outstanding
1,24 ຕື້
No. of employees
17 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
36 ນາທີກ່ອນ
43 ETFs Add to Gilead Sciences (GILD) on Thursday
ad-hoc-news.de
·
3 ຊົ່ວໂມງກ່ອນ
Gilead Sciences stock sits 2.32 percent below its yearly high
ad-hoc-news.de
·
5 ຊົ່ວໂມງກ່ອນ
Gilead Sciences stock pre-market at EUR 139.78: biotech group slightly higher
The Motley Fool
·
17 ຊົ່ວໂມງກ່ອນ
Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences Inc BDR
CEODaniel O'Day
Employees17 ພັນ
Founded22 ມິ.ຖ. 1987
HeadquartersFoster City, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitegilead.com